tenk.fyi

Vir Biotechnology, Inc.

VIRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$68.6M

7.6% YoY

Net Income

-$438.0M

16.1% YoY

EPS

$-3.16

17.5% YoY

Cash

$232.2M

4.1% YoY

FY 2025 · As of 2025-12-31